Ronald G. Tilton
Department of Cell Biology
Texas Biotechnology Corporation
Houston 77030
USA
Name/email consistency: high
- Diabetic vascular dysfunction: links to glucose-induced reductive stress and VEGF. Tilton, R.G. Microsc. Res. Tech. (2002)
- Therapeutic potential of endothelin receptor antagonists and nitric oxide donors in pulmonary hypertension. Tilton, R.G., Brock, T.A., Dixon, R.A. Expert. Opin. Investig. Drugs (2001)
- Attenuation of pulmonary vascular hypertension and cardiac hypertrophy with sitaxsentan sodium, an orally active ET(A) receptor antagonist. Tilton, R.G., Munsch, C.L., Sherwood, S.J., Chen, S.J., Chen, Y.F., Wu, C., Block, N., Dixon, R.A., Brock, T.A. Pulm. Pharmacol. Ther (2000)
- Vascular dysfunction induced by elevated glucose levels in rats is mediated by vascular endothelial growth factor. Tilton, R.G., Kawamura, T., Chang, K.C., Ido, Y., Bjercke, R.J., Stephan, C.C., Brock, T.A., Williamson, J.R. J. Clin. Invest. (1997)









